XML 100 R73.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS - Movantik Acquisition (Details) - USD ($)
$ in Thousands
 12 Months Ended
Apr. 01, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Sep. 30, 2020
Disclosure of detailed information about intangible assets [line items]          
Upfront payment for acquisition of rights   $ 53,368 $ 35 $ 35  
Agreement amount payable for acquisition of rights   26,600      
Intangible assets   $ 87,879 $ 16,927    
Movantik          
Disclosure of detailed information about intangible assets [line items]          
Percentage of royalty based on sales   20.00%      
Intangible assets   $ 12,500      
Present value of total consideration   $ 65,000      
Useful life of assets (in years)   10 years 6 months      
Fee on net revenue for services received (as a percent)         4.50%
Aemcolo          
Disclosure of detailed information about intangible assets [line items]          
Useful life of assets (in years)   11 years      
Recoverable amount of intangible asset   $ 9,800      
AstraZeneca AB | Movantik          
Disclosure of detailed information about intangible assets [line items]          
Upfront payment for acquisition of rights $ 52,500        
Agreement amount payable for acquisition of rights   15,500      
Purchase commitment   $ 25,000